TY - JOUR
T1 - Galanin infusion partially restores the blunted growth hormone responses to repeated growth hormone releasing hormone stimuli in normal adults
AU - Sartorio, Alessandro
AU - Spada, A.
AU - Conti, A.
AU - Grugni, G.
AU - Morabito, F.
AU - Faglia, G.
PY - 1993
Y1 - 1993
N2 - In order to understand the role exerted by the endogenous somatostatinergic tone in the blunting of GH responsiveness to repeated GHRH administration, we evaluated GH responses to the second GHRH bolus during a simultaneous infusion of galanin, which has been reported to inhibit the endogenous somatostatin release. Seven normal adults (3M/4F, age range 19–28 yr), admitted to the study after giving informed consent, were tested on three occasions, with a) two consecutive 1 μg/kg iv GHRH boluses administered at 0 min and 120 min, b) one GHRH bolus at 0 min followed by an infusion of 10 μ/kg bw galanin (diluted in 40 ml 0.9% NaCI) between 100 min and 140 min and c) two consecutive GHRH boluses (same dose and temporization of administration of test a) associated with a galanin infusion from 100 min to 140 min. GH responses were evaluated as the net incremental area under the curve (GH nAUC/h); all data were expressed as mean±SE. GH responses to the first GHRH bolus were similar in the three tests (mean GH nAUC, test A 990±80, test B: 1006±112, test C: 1077±80 ng/ml/h). In test A the second GHRH bolus was unable to sustain GH elevated levels (mean GH nAUC: 32±12 ng/ml/h vs first GHRH: 990±80 ng/ml/h, p
AB - In order to understand the role exerted by the endogenous somatostatinergic tone in the blunting of GH responsiveness to repeated GHRH administration, we evaluated GH responses to the second GHRH bolus during a simultaneous infusion of galanin, which has been reported to inhibit the endogenous somatostatin release. Seven normal adults (3M/4F, age range 19–28 yr), admitted to the study after giving informed consent, were tested on three occasions, with a) two consecutive 1 μg/kg iv GHRH boluses administered at 0 min and 120 min, b) one GHRH bolus at 0 min followed by an infusion of 10 μ/kg bw galanin (diluted in 40 ml 0.9% NaCI) between 100 min and 140 min and c) two consecutive GHRH boluses (same dose and temporization of administration of test a) associated with a galanin infusion from 100 min to 140 min. GH responses were evaluated as the net incremental area under the curve (GH nAUC/h); all data were expressed as mean±SE. GH responses to the first GHRH bolus were similar in the three tests (mean GH nAUC, test A 990±80, test B: 1006±112, test C: 1077±80 ng/ml/h). In test A the second GHRH bolus was unable to sustain GH elevated levels (mean GH nAUC: 32±12 ng/ml/h vs first GHRH: 990±80 ng/ml/h, p
KW - Galanin
KW - GH
KW - GHRH
KW - normals
UR - http://www.scopus.com/inward/record.url?scp=0027419808&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027419808&partnerID=8YFLogxK
U2 - 10.1007/BF03347656
DO - 10.1007/BF03347656
M3 - Article
C2 - 7681861
AN - SCOPUS:0027419808
SN - 0391-4097
VL - 16
SP - 95
EP - 98
JO - Journal of Endocrinological Investigation
JF - Journal of Endocrinological Investigation
IS - 2
ER -